Foresite Capital Management V, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 6Value: $87.6MLatest: 2025Q1

Foresite Capital Management V, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 6 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ALMS",
  "LYEL",
  null,
  "HIMS",
  "CGON",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 6
Total Value: 87616861
Accession Number: 0001104659-25-049396
Form Type: 13F-HR
CIK: foresite-capital-management-v
Manager Name: Foresite-Capital-Management-V

Data Enrichment

83% identified

5 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

6 positions • $87.6M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

ALUMIS INC.

ALMS|022307102

Shares:5.8M

Value:$35.5M

% of Portfolio:40.5% ($35.5M/$87.6M)

CG Oncology, Inc.

CGON|156944100

Shares:859.0K

Value:$21.0M

% of Portfolio:24.0% ($21.0M/$87.6M)

Disc Medicine, Inc.

IRON|254604101

Shares:299.1K

Value:$14.8M

% of Portfolio:16.9% ($14.8M/$87.6M)

Hims & Hers Health, Inc.

HIMS|433000106

Shares:273.2K

Value:$8.1M

% of Portfolio:9.2% ($8.1M/$87.6M)

Lyell Immunopharma, Inc.

LYEL|55083R104

Shares:8.1M

Value:$4.4M

% of Portfolio:5.0% ($4.4M/$87.6M)

578784100

Shares:345.2K

Value:$3.8M

% of Portfolio:4.3% ($3.8M/$87.6M)

Instrument	Shares		Other Manager	Value	% of Portfolio
ALUMIS INC.(ALMScusip022307102)	5.8M	QoQ 0.00% (-0) YoY NEW(+5.8M)	All Managers (Combined)	$35.5M	40.5% ($35.5M/$87.6M)	QoQ -21.88% (-$9.9M) YoY NEW(+$35.5M)
CG Oncology, Inc.(CGONcusip156944100)	859.0K	QoQ +24.04% (+166.5K) YoY +24.04% (-166.5K)	All Managers (Combined)	$21.0M	24.0% ($21.0M/$87.6M)	QoQ +5.91% (+$1.2M) YoY -30.80% (-$9.4M)
Disc Medicine, Inc.(IRONcusip254604101)	299.1K	QoQ 0.00% (-0) YoY +22.81% (-55.6K)	All Managers (Combined)	$14.8M	16.9% ($14.8M/$87.6M)	QoQ -21.70% (-$4.1M) YoY -2.07% (-$315.3K)
Hims & Hers Health, Inc.(HIMScusip433000106)	273.2K	QoQ -70.93% (-666.7K) YoY -91.78% (-3.1M)	All Managers (Combined)	$8.1M	9.2% ($8.1M/$87.6M)	QoQ -64.48% (-$14.7M) YoY -84.31% (-$43.4M)
Lyell Immunopharma, Inc.(LYELcusip55083R104)	8.1M	QoQ 0.00% (-0) YoY NEW(+8.1M)	All Managers (Combined)	$4.4M	5.0% ($4.4M/$87.6M)	QoQ -15.93% (-$829.6K) YoY NEW(+$4.4M)
(cusip578784100)✕	345.2K	QoQ NEW(+345.2K) YoY NEW(+345.2K)	All Managers (Combined)	$3.8M	4.3% ($3.8M/$87.6M)	QoQ NEW(+$3.8M) YoY NEW(+$3.8M)